Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RSHO CBD
- Development stage
- Preclinical
- Lead developer
- HempMeds
- Modality
- Small Molecules
- Administration
- Oral, Topical, Sublingual
01
Overview
RSHO (Real Scientific Hemp Oil) is a line of hemp-derived cannabidiol (CBD) products developed by HempMeds, a subsidiary of Medical Marijuana, Inc. The product line includes various formulations such as Green Label (unfiltered), Blue Label (decarboxylated), Gold Label (filtered), and RSHO-X (THC-free isolate). Extracted from industrial hemp using supercritical CO2, RSHO contains non-psychoactive CBD that interacts with the endocannabinoid system (ECS). While marketed as a dietary supplement, RSHO has been utilized in clinical research for a wide range of conditions, including pediatric epilepsy, multiple sclerosis spasticity, and neurodegenerative diseases, due to its purported anti-inflammatory, neuroprotective, and anticonvulsant properties.
- Brand names
- RSHOReal Scientific Hemp OilRSHO-X
- Other names
- HempMeds CBD
02
Targets
CNR1 (Cannabinoid receptor 1)PPARG (Peroxisome proliferator-activated receptor gamma)NaV (Voltage-gated sodium channels)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))TRPV1 (Transient receptor potential cation channel subfamily V member 1)FAAHADOR (Adenosine receptors)CaV (Voltage-gated calcium channel protein complex)GABAA (Gamma-aminobutyric acid receptor)Kir (Inward-rectifier potassium channels)
Beyond the preview
Go deeper on RSHO CBD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RSHO CBD.